Submitted by kw643 on Wed, 06/05/2026 - 10:30
How Stress Hormone Cortisol Shapes Cancer-Fighting T Cells
A groundbreaking paper from the Mahata Lab in the Department of Pathology reveals how the stress hormone cortisol can rewire the behaviour of human “killer” T cells (CD8 T cells), which play a key role in controlling cancer. The study shows that cortisol alters how these cells read and use their genetic information, helping to push them towards a tired, less effective state inside tumours.
What the Study Explores
· Investigates how the stress hormone cortisol changes the activity of human CD8 T cells.
· Focuses on how a stress hormone (cortisol) receptor inside the cell’s nucleus works together with other key regulatory proteins to control whether T cells stay active or become dysfunctional.
· Uses a combination of modern genetic and single‑cell technologies, along with data from several human cancers, to map these changes.
Key Discoveries
· Cortisol rewires T cell programs: Cortisol shifts the balance of gene activity in CD8 T cells, turning down immune “attack” programs.
· A new partnership inside T cells: The cortisol receptor does not act alone; it frequently partners with other gene‑decoding factors to control which genes are switched on or off, revealing an unexpected way stress hormones influence immunity.
· Direct link to T cell exhaustion in cancer: The combined gene expression patterns driven by cortisol are strongly enriched in T cells found inside breast, lung, head and neck, and pancreatic tumours, especially in cells that show signs of being worn out or exhausted.
Together, these findings support a model in which stress hormones present at high levels in the tumour environment can quietly steer T cells away from effective cancer‑killing activity and towards a less helpful, dysfunctional state.
Why This Research Is Important
· Improved disease understanding: The work explains one way in which the body’s own stress hormones can weaken immune responses against cancer by changing how T cells decide what to do.
· Better treatment strategies: By identifying the key steps in this hormone‑driven control system, the study suggests potential new ways to protect T cells from becoming exhausted
without removing the beneficial effects of stress hormones elsewhere in the body, although further research will be needed to translate this into therapies.
· Advances in immuno‑oncology: These insights can inform how doctors use steroids in cancer patients and how new therapies might be designed to keep T cells in a more active, cancer‑fighting state.
Real-World Impact
This work from the Mahata Lab could contribute to:
· New treatments that “shield” T cells from the negative effects of stress hormones inside tumours, helping them stay in fighting shape for longer.
· Smarter use of steroid drugs in cancer care, taking into account their impact on the body’s own immune defences.
· Future tests that read T cell hormone‑response patterns in tumours to help guide therapy choices.
The Bigger Picture
By revealing how the stress hormone cortisol influences the inner decision‑making of cancer‑fighting T cells, the Mahata Lab’s research highlights a subtle but powerful way in which the tumour environment can shape anti‑tumour immunity. It shows that T cells are not simply on or off, but are context‑dependent decision‑makers whose behaviour is tuned by signals such as stress hormones—an insight that may help doctors better harness the immune system against cancer.